NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
TOP NEWS
Wuxi Pharma Tech
»07/12/2009 [Company watch]
WuXi PharmaTech buys Labcyte product for High-Throughput Screening

WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and US, has announced that it has purchased a Labcyte POD 810 plate assembler equipped with an Echo 555 acoustic liquid handler for its work in high-throughput screening and secondary screening.

 
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and US, has announced that it has purchased a Labcyte POD 810 plate assembler equipped with an Echo 555 acoustic liquid handler for its work in high-throughput screening and secondary screening. WuXi PharmaTech joins the growing number of pharmaceutical companies worldwide that have incorporated the POD system into their compound management and HTS processes. \"With this technology WuXi will remain the leader in pharmaceutical outsourcing-this demonstrates our continuous efforts to build both capabilities and capacity to help our partners to improve the success of discovery and shorten development time,\" said Dr Ge Li, Chairman, WuXi PharmaTech. \"Acoustic liquid handling is clearly the method of choice in drug discovery,\" said Dr Qiang Lu, VP of Discovery Biology, WuXi PharmaTech. \"We are very pleased to incorporate the POD 810 into our systems. It will make our drug discovery efforts significantly more productive while it reduces cost through the elimination of disposable plastic tips. We know that acoustic liquid handling will significantly improve the quality of the data we generate. We are looking forward to a continuing relationship with Labcyte.\" The POD 810 plate assembler, a walk-away, out-of-the-box solution, transforms any Echo acoustic liquid handler into a Plates-On-Demand instrument. The POD system is controlled by its revolutionary Intellectual Scheduler with built-in intelligence to automatically adjust workflow to maximize productivity. \"The POD platform is uniquely positioned to advance method standardization across global sites,\" said Mr Mark Fischer-Colbrie, President, Labcyte. \"It eliminates the unnecessary delays associated with customized integration.\" \"We are very pleased WuXi PharmaTech decided to acquire a Labcyte POD system,\" said Mr Sanger Chang, General Manager of Tekon Biotech. \"Our exclusive relationship with Labcyte is further validation of our efforts to be the leading supplier of instrument systems for pharmaceutical research to the Chinese market by providing the highest level of technical support and service.\"

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.